The Galway company’s attempts to raise a $50m Series C round fell through and a liquidator has been called in just weeks after it published the results of its latest clinical trial.
The Western Development Commission is a frequent investor in medtech in the West of Ireland. The Currency examines the depth of those investments and potential risks of over-reliance.
Megadale makes equipment for the medtech and life-sciences sectors but a cancelled contract by a major multinational forced the company into liquidation.
The multinational has struck a deal to sell its Galway design and manufacturing hub to Quasar Medical. Its Roscommon site is untouched by the deal.
Loughrea’s 360° Underwriting, which focuses on construction insurance, will be absorbed into Ryan Specialty as a “natural entry point” to the Irish market.
Europa Metals was tipped to build a recycling facility on the site to reclaim up to €1 billion worth of mining waste tailings but the firm has pulled the plug on the deal.
Roebuck Foods was in the business of milking cows, and meat and dairy trade and logistics. It is now on course to raise up to €10m to acquire a Galway start-up addressing livestock’s methane emissions.
The Galway medtech start-up is preparing trials for its device for diabetics in the US and is planning a funding round in the coming months.
The US-listed company, which owns a medical device plant in Galway, moved its incorporation – and tax residence – from Switzerland to Ireland this week.
The heavy-duty battery pack maker has seen its revenue more than double in the last year and now plans to raise up to €30 million in additional capital to expand further in the US.
© 2026 Currency Media Limited
